Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.4 EUR | -0.73% | 0.00% | -4.80% |
06-24 | Hutchmed China notes Takeda obtains EU approval for Fruzaqla | AN |
06-24 | Takeda's Organ Transplant Infection Treatment Approved by Japan Regulators | MT |
Chart: Technical Analysis
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- 4502 Stock
- TKD Stock
- Charts Takeda Pharmaceutical Company Limited